Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study
| Autor: | Gelderblom, H., Blay, J.Y., Seddon, B.M., Leahy, M., Ray-Coquard, I., Sleijfer, S., Kerst, J.M., Rutkowski, P., Bauer, S., Ouali, M., Marreaud, S., van der Straaten, R.J.H.M., Guchelaar, H.-J., Weitman, S.D., Hogendoorn, P.C.W., Hohenberger, P. |
|---|---|
| Zdroj: | In European Journal of Cancer January 2014 50(2):388-396 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect